U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07216365) titled 'Caffeine Optimization for Oxygen Saturation Index in ELBW Infants' on Sept. 05.
Brief Summary: The goal of this clinical trial is to determine whether a higher dose of caffeine citrate can improve breathing and reduce health complications in extremely premature infants, specifically those born before 28 weeks of pregnancy, known as ELGAN infants. These babies often struggle with breathing due to underdeveloped lungs, and caffeine is commonly used to help support their respiratory function. However, the most effective and safest dose has not yet been clearly established.
The study aims to answer two main questions: Does a higher mai...